An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression
1993
Flesinoxan, a full 5-HT1A, receptor agonist, was administered (4–8 mg) to treatment-resistant depressed patients in an open study. Safety and tolerance of the substance appeared satisfactory. Headache, dizziness and nausea were the most frequently reported side effects. The observations suggested th
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
49
Citations
NaN
KQI